We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

The world’s first genetically edited polo horses are here, all thanks to the efforts of a biotech firm based in Argentina.

We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...

No matter the market sentiment, gene editing is still a big deal for medical and pharmaceutical companies as well as patients and doctors. Two of the leading firms in the sector are CRISPR ...

This is a mechanism that can edit the genomes of humans, pathogens, and plants. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats, and Cas9 (which stands for CRISPR ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it ...

CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...